This study assessed the cumulative incidence of cardiovascular evens after zotarolimus eluting stent implantation.   Individual studies often lack enough statistical power to show differences in low frequency adverse events. The Resolute zotarolimus eluting stent was evaluated across 10 prospective clinical trials designed with identical adverse events definitions.   The Global Resolute clinical trial program…